Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

338 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance in People Initiating Nonnucleoside Reverse Transcriptase Inhibitor-Containing Antiretroviral Therapy: A Systematic Review and Meta-analysis.
Bertagnolio S, Hermans L, Jordan MR, Avila-Rios S, Iwuji C, Derache A, Delaporte E, Wensing A, Aves T, Borhan ASM, Leenus A, Parkin N, Doherty M, Inzaule S, Mbuagbaw L. Bertagnolio S, et al. Among authors: mbuagbaw l. J Infect Dis. 2021 Aug 2;224(3):377-388. doi: 10.1093/infdis/jiaa683. J Infect Dis. 2021. PMID: 33202025 Free PMC article. Review.
Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals.
Mbuagbaw L, Mursleen S, Irlam JH, Spaulding AB, Rutherford GW, Siegfried N. Mbuagbaw L, et al. Cochrane Database Syst Rev. 2016 Dec 10;12(12):CD004246. doi: 10.1002/14651858.CD004246.pub4. Cochrane Database Syst Rev. 2016. PMID: 27943261 Free PMC article. Review.
Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations.
Haberer JE, Sabin L, Amico KR, Orrell C, Galárraga O, Tsai AC, Vreeman RC, Wilson I, Sam-Agudu NA, Blaschke TF, Vrijens B, Mellins CA, Remien RH, Weiser SD, Lowenthal E, Stirratt MJ, Sow PS, Thomas B, Ford N, Mills E, Lester R, Nachega JB, Bwana BM, Ssewamala F, Mbuagbaw L, Munderi P, Geng E, Bangsberg DR. Haberer JE, et al. Among authors: mbuagbaw l. J Int AIDS Soc. 2017 Mar 22;20(1):21371. doi: 10.7448/IAS.20.1.21371. eCollection 2017. J Int AIDS Soc. 2017. PMID: 28630651 Free PMC article.
Agreement in reporting between trial publications and current clinical trial registry in high impact journals: A methodological review.
Kosa SD, Mbuagbaw L, Borg Debono V, Bhandari M, Dennis BB, Ene G, Leenus A, Shi D, Thabane M, Valvasori S, Vanniyasingam T, Ye C, Yranon E, Zhang S, Thabane L. Kosa SD, et al. Among authors: mbuagbaw l. Contemp Clin Trials. 2018 Feb;65:144-150. doi: 10.1016/j.cct.2017.12.011. Epub 2017 Dec 26. Contemp Clin Trials. 2018. PMID: 29287666 Review.
A systematic review of comparisons between protocols or registrations and full reports in primary biomedical research.
Li G, Abbade LPF, Nwosu I, Jin Y, Leenus A, Maaz M, Wang M, Bhatt M, Zielinski L, Sanger N, Bantoto B, Luo C, Shams I, Shahid H, Chang Y, Sun G, Mbuagbaw L, Samaan Z, Levine MAH, Adachi JD, Thabane L. Li G, et al. Among authors: mbuagbaw l. BMC Med Res Methodol. 2018 Jan 11;18(1):9. doi: 10.1186/s12874-017-0465-7. BMC Med Res Methodol. 2018. PMID: 29325533 Free PMC article.
Antiretroviral resistance testing in HIV-positive people.
Aves T, Tambe J, Siemieniuk RA, Mbuagbaw L. Aves T, et al. Among authors: mbuagbaw l. Cochrane Database Syst Rev. 2018 Nov 9;11(11):CD006495. doi: 10.1002/14651858.CD006495.pub5. Cochrane Database Syst Rev. 2018. PMID: 30411789 Free PMC article.
338 results